Ryan Richardson, BioNTech chief strategy officer
BioNTech touts differences with Moderna in race for cancer vaccines
BioNTech chief strategy officer Ryan Richardson highlighted the differences between his company’s cancer vaccine and another under development by Moderna and Merck, as the companies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
